Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 96-100 , April 2009

Bridging the Survival Gap Between Indigenous and Non-Indigenous Australians: Priorities for the Road Ahead

  • Alex Brown

      Affiliations

    • Centre for Indigenous Vascular and Diabetes Research, Baker IDI Heart and Diabetes Institute, 4/19 Hartley Street, Alice Springs, NT 0870, Australia
    • School of Population Health, University of Queensland, St Lucia Qld 4072, Australia
    • Corresponding Author InformationCorrespondence address: Centre for Indigenous Vascular and Diabetes Research, Baker IDI Heart and Diabetes Institute, 4/19 Hartley Street, Alice Springs, NT 0870, Australia. Tel.: +61 8 8959 0111; fax: +61 8 8952 1557.
    web address

References 

  1. Australian Bureau of Statistics and Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples. ABS Catalogue No. 4704.0. AIHW Catalogue No. IHW 21. Canberra: ABS and AIHW; 2008.
  2. Marmot M. Achieving health equity: from root causes to fair outcomes. The Lancet. 2007;370(9593):1153–1163
  3. The World Health Report 2003. Shaping the Future. Geneva: World Health Organization; 2003.
  4. Zhao Y, Dempsey K. Causes of inequality in life expectancy between Indigenous and non-Indigenous people in the Northern Territory 1981-2000: a decomposition analysis. Med J Aust. 2006;184:490–494
  5. Brown A, Brown N. The Northern Territory intervention: voices from the centre of the fringe. Med J Aust. 2007;187(11–12):621–623
  6. Australian Bureau of Statistics. Population Distribution, Aboriginal and Torres Strait Islander Australians, 2006, Cat. no. 4705.0. Canberra: ABS; 2007.
  7. O’Dea K. Cardiovascular disease risk factors in Australian Aborigines. Clin Exp Pharmacol Physiol. 1991;18:85–88
  8. McDermott R, Saraswati K, Tilmouth R, Roberts I, Fitz J, Wang Z, et al. Lower than expected morbidity and mortality for an Australian Aboriginal population: 10 year follow up in a decentralised community. Med J Aust. 2008;188(5):283–287
  9. Brown A. Quality Use of Cardiovascular Medicines in Indigenous Australians: Future Directions. On Behalf of the National Heart Foundation Pharmaceutical Roundtable. Melbourne: NHFA; 2007.
  10. Kelaher M, Taylor-Thompson D, Harrison N, O’Donoghue L, Dunt D, Barnes T. Evaluation of PBS medicine supply arrangements for remote area aboriginal health services under S100 of the National Health Act: Co-operative Research Centre for Aboriginal Health and Program Evaluation Unit. University of Melbourne; 2005;
  11. Cass A, Lowell A, Christie M, Snelling PL, Flack M, Marrnganyin B, et al. Sharing the true stories: improving communication between Aboriginal patients and healthcare workers. Med J Aust. 2002;176(10):466–470
  12. Access Economics. The growing costs of obesity in 2008: three years on Access Economics; 2008.
  13. van der Weijden T, Bos L, Koelewijn-van Loon M. Primary care patients’ recognition of their own risk for cardiovascular disease: implications for risk communication in practice. Curr Opin Cardiol. 2008;23(5):471–476
  14. Devitt J, McMasters A. ’They don’t last long’: Aboriginal patients experience of end-stage renal disease in Central Australia. Nephrology. 1998;4(Supplement 2):S111–S117
  15. Cass A, Cunningham J, Wang Z, Hoy W. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust. 2001;175(1):24–27Jul 2
  16. Coory M, Walsh W. Rates of percutaneous coronary interventions and bypass surgery after acute myocardial infarction in Indigenous patients. Med J Aust. 2005;182:507–512
  17. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?. Med J Aust. 2005;182(2):66–69Jan 17

PII: S1443-9506(09)00044-4

doi: 10.1016/j.hlc.2009.01.005

Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 96-100 , April 2009